Abstract
The Helsinki Declaration is the ‘gold standard’ — a directive, not a law, on how to conduct controlled studies in humans in conformity with ethical principles. In spite of many discussions about their unsuitability some articles have remained unchanged in the most recent (sixth) revision of the Declaration. The demand to use “the best treatment” excludes use of placebo in the control group and presents an obstacle to the scientific evaluation of a number of drugs and treatments in general. The use of placebo is justified whenever its use does not cause irreversible damage or considerable suffering to the well informed patient. It must be, is, and will be used in the controlled clinical trials of treatments of a great number of diseases especially those which have a tendency to spontaneous improvement, even healing, or have a pronounced psychological component
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pearsal J. (ed.) (1999) Concise Oxford dictionary, 10th ed., Oxford Univ. Press, Oxford
Dorland’s Illustrated Medical Dictionary (1994) 28th ed., Saunders, Philadelphia
Kane A. (2002) The problem pill for every ill, SCRIP Mag Issue 118: 8–9.
Hill A.B. (1984) Principles of medical statistics, Hodder & Stoughton, London.
World Medical Association Declaration of Helsinki (1996) http://www.va.gov/over/docs/compendium_1/files Helsinki 96 htm.
Anonymous (2000) WMA 2000 Declaration of Helsinki. Ethical principles for medical research involving human subjects, JAMA 284: 3043–45; also available 2000: http://www.wma.net/e/policy/17c_e.html; 2003: http://www.chsr.od.nih.gov/helsinki.php.3.
Diamant J.C. (2002) The revised Declaration of Helsinki — Is justice served? Int J clinpharmacol ther 40: 76–83.
Huston P. and Peterson R. (2001) Withholding proven treatment in clinical research. N Engl J Med 345: 912–914.
Moreno J.D. (2001) Placebo on trial, Ann Neurol 49: 558–560.
Temple R. and Ellenberg Susan S. (2000) Placebo-controlled trials and active-controlled trials in the evaluation of new treatments Ann Int Med 133: 455–463.
Ellenberg Susan S. and Temple R. (2000) idem 133: 464–470.
The Digoxin Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336: 525–33.
Anonymous (2003) Hormontherapie substitutive de la menopause: Des risques cardiovasculaires, Rev Prescr 23: 27–33.
Lasagna L. (1979) Placebos and controlled trials under attack (Editorial), Eur J clin pharmacol 15: 373–4.
Beasley C.M., Jr, Domself B.E., Bosomworth et al. (1991) Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression, Brit med J 303: 685–92.
Carpenter W.T., Jr., Schooler N.R. and Kane J.M. (1997) The rational and ethics of medication-free research in schizophrenia, Arch. Gen. Psychiatry 54: 401–7.
Family says UCLA experiment harmed their son, ethicists says psychiatrists violated Nuremberg code of principles. ABC 20/20 (1997) (transcript)/accessed August 31, 2001, at http://www.ect.org/rattler/ethics.html
Hacke W., Kaste M., Fieschi C., von Kummer, R. et al. (1998) Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alterplase in acute ischemic stroke (ECASSII). Second European-Astralasian Acute stroke study Investigators, Lancet 352: 1245–51.
Lewis J.A., Jonsson B. Kreutz G., et al. (2002) Placebo-controlled trials and the Declaration of Helsinki, Lancet 359: 1337–40.
Sternfeld D. (2002) Testing times ahead for children in Europe, SCRIP Mag issue 109: 16–17.
Horng S., Miller F.G. (2002) Is placebo surgery unethical? N Engl J Med 347: 137–39
Gillet G.R. (2001) Unnecessary holes in the head, IRB Ethics, Hum Res 23: 1–6.
Authors not cited (2002) A randomized, double blind, placebo-controlled multicenter trial comparing effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy, Sleep 25: 42–44.
Marcellin P., Chang T.T., Lim S.G., et al. (2003) Adefovir dipivoxil for the treatment of hepatitis B e antigen positive chronic hepatitis B, N Engl J Med 384: 808–816.
Anonymous, Alinia (nitazoxanide), Review produced by the manufacturer December 2002.
Rothman K.J. and Michels K.B. (1994) The continued unethical use of placebo controls, N Engl J med 331: 394–98.
Anonymous (1998) Statistical principles for clinical trials, ICH topic E9 EMEA London
Anonymous (2001) EMEA/CPMP position statement on the use of placebo in clinical trials with regard to the revised declaration of Helsinki EMEA/17424/01 London
Sicard D. (2000) personal communication.
Anonymous (2002) International ethical guidelines for biomedical research involving human subjects, CIOMS. Geneva.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vrhovac, B. Placebo and the helsinki declaration — What to do?. SCI ENG ETHICS 10, 81–93 (2004). https://doi.org/10.1007/s11948-004-0066-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11948-004-0066-9